BioPharmSignal logoBioPharmSignal

Biotech News

Outset Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference

Outset Medical (OM)Outset MedicalConference / presentation

SAN JOSE, Calif. , Jan. 05, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that Chair & CEO Leslie Trigg will present at the 44 th annual

Related news

LUNGPulmonx2026-07-28 20:05 EST

Pulmonx to Present at the Canaccord Genuity 46th Annual Growth Conference

IARTIntegra LifeSciences2026-06-15 12:30 EST

Integra LifeSciences to Present at the 2026 Truist Securities MedTech Conference

TMCITreace Medical Concepts2026-06-11 20:05 EST

Treace to Present at the Sidoti Small Cap Conference

IRIXIRIDEX2026-06-09 20:05 EST

Iridex to Present at the Planet MicroCap Las Vegas 2026 Conference

PRCTPROCEPT BioRobotics2026-08-17 12:00 EST

PROCEPT BioRobotics® to Attend the Baird 2026 Global Healthcare Conference on September 15, 2026

PLSEPulse Biosciences2026-07-30 20:05 EST

Pulse Biosciences to Present at Canaccord Genuity’s 46th Annual Growth Conference

CVRXCVRx2026-07-28 12:30 EST

CVRx to Present at Canaccord Genuity's 46th Annual Growth Conference

XTNTXtant Medical2026-08-04 20:05 EST

Xtant Medical to Participate in the Canaccord Genuity 46th Annual Growth Conference

ICUSeaStar Medical2026-06-22 12:45 EST

SeaStar Medical to Present at Upcoming Investor Summit Conference

OMOutset Medical2026-08-06 20:01 EST

Outset Medical Reports Second Quarter 2026 Results

View all latest news

Outset Medical

Dialysis Technology Outset Medical develops technology intended to simplify dialysis delivery across hospitals, clinics and home-care settings. Tablo Hemodialysis System Tablo is an integrated hemodialysis system that combines water purification, on-demand dialysate production and treatment delivery in a single device. Its design seeks...

Recent company news

OMOutset Medical2026-08-06 20:01 EST

Outset Medical Reports Second Quarter 2026 Results

OMOutset Medical2026-07-23 13:00 EST

Outset Medical to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026

OMOutset Medical2026-07-02 20:05 EST

Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

OMOutset Medical2026-05-21 20:05 EST

Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

OMOutset Medical2026-05-11 20:05 EST

Outset Medical to Present at RBC Global Healthcare Conference

Stock data

Close
4.21 USD
Market cap
93.98M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States